WallStreetZenWallStreetZen

NASDAQ: PBM
Psyence Biomedical Ltd Earnings & Revenue

PBM earnings and revenue history

Current Revenue
$0.0
Current Earnings
$1.5M
Current Profit Margin
0%

PBM Return on Equity

Current Company
-10.1%
Current Industry
15.4%
Current Market
-9.4%
PBM's Return on Equity (-10.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PBM announces earnings.

PBM Return on Assets

Current Company
2%
Current Industry
2.2%
PBM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PBM Return on Capital Employed

Current Company
-43.33%
Current Industry
17.7%

PBM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PBM$0.00$1.52M$1.52MN/AN/A
SNPX$0.00-$4.53M-$12.23MN/AN/A
VIRI$0.00-$5.07M-$5.07MN/AN/A
CERON/AN/AN/AN/AN/A
GOVX$0.00-$27.70M-$27.78M-100.00%N/A

Psyence Biomedical Earnings & Revenue FAQ

What were PBM's earnings last quarter?

Psyence Biomedical (NASDAQ: PBM) reported Q3 2023 earnings per share (EPS) of -$0.08, up Infinity% year over year. Total Psyence Biomedical earnings for the quarter were -$647.77 thousand. In the same quarter last year, Psyence Biomedical's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Psyence Biomedical stock.

What was PBM's earnings growth in the past year?

As of Q2 2024, Psyence Biomedical's earnings has grown year over year. Psyence Biomedical's earnings in the past year totalled $1.52 million.

What was PBM's revenue last quarter?

Psyence Biomedical (NASDAQ: PBM) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Psyence Biomedical's revenue was $0.00.

What was PBM's revenue growth in the past year?

As of Q2 2024, Psyence Biomedical's revenue has grown null year over year. Psyence Biomedical's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.